BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 18483365)

  • 21. Expression of annexin A1 in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
    Wang KL; Wu TT; Resetkova E; Wang H; Correa AM; Hofstetter WL; Swisher SG; Ajani JA; Rashid A; Hamilton SR; Albarracin CT
    Clin Cancer Res; 2006 Aug; 12(15):4598-604. PubMed ID: 16899607
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methylation of protocadherin 10, a novel tumor suppressor, is associated with poor prognosis in patients with gastric cancer.
    Yu J; Cheng YY; Tao Q; Cheung KF; Lam CN; Geng H; Tian LW; Wong YP; Tong JH; Ying JM; Jin H; To KF; Chan FK; Sung JJ
    Gastroenterology; 2009 Feb; 136(2):640-51.e1. PubMed ID: 19084528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The potential role of Bcl-2 expression, apoptosis and cell proliferation (Ki-67 expression) in cases of gastric carcinoma and correlation with classic prognostic factors and patient outcome.
    Tsamandas AC; Kardamakis D; Tsiamalos P; Liava A; Tzelepi V; Vassiliou V; Petsas T; Vagenas K; Zolota V; Scopa CD
    Anticancer Res; 2009 Feb; 29(2):703-9. PubMed ID: 19331225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Absence of RKIP expression is an independent prognostic biomarker for gastric cancer patients.
    Martinho O; Simões K; Longatto-Filho A; Jacob CE; Zilberstein B; Bresciani C; Gama-Rodrigues J; Cecconello I; Alves V; Reis RM
    Oncol Rep; 2013 Feb; 29(2):690-6. PubMed ID: 23232914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systematic analysis of proteins from different signaling pathways in the tumor center and the invasive front of colorectal cancer.
    Karamitopoulou E; Zlobec I; Panayiotides I; Patsouris ES; Peros G; Rallis G; Lapas C; Karakitsos P; Terracciano LM; Lugli A
    Hum Pathol; 2011 Dec; 42(12):1888-96. PubMed ID: 21664646
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of signal transducer and activator of transcription 3 in renal cell carcinoma: a study of incidence and its association with pathological features and clinical outcome.
    Horiguchi A; Oya M; Shimada T; Uchida A; Marumo K; Murai M
    J Urol; 2002 Aug; 168(2):762-5. PubMed ID: 12131365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Morphoproteomic profile of mTOR, Ras/Raf kinase/ERK, and NF-kappaB pathways in human gastric adenocarcinoma.
    Feng W; Brown RE; Trung CD; Li W; Wang L; Khoury T; Alrawi S; Yao J; Xia K; Tan D
    Ann Clin Lab Sci; 2008; 38(3):195-209. PubMed ID: 18715846
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Positive correlation of osteopontin, cyclooxygenase-2 and vascular endothelial growth factor in gastric cancer.
    Tang H; Wang J; Bai F; Zhai H; Gao J; Hong L; Xie H; Zhang F; Lan M; Yao W; Liu J; Wu K; Fan D
    Cancer Invest; 2008 Feb; 26(1):60-7. PubMed ID: 18181047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Claudin-4, mitogen-activated protein kinase kinase 4, and stratifin are markers of gastric adenocarcinoma precursor lesions.
    Cunningham SC; Kamangar F; Kim MP; Hammoud S; Haque R; Iacobuzio-Donahue CA; Maitra A; Ashfaq R; Hustinx S; Heitmiller RE; Choti MA; Lillemoe KD; Cameron JL; Yeo CJ; Schulick RD; Montgomery E
    Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):281-7. PubMed ID: 16492916
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced expression of Raf-1 kinase inhibitory protein in renal cell carcinoma: a significant prognostic marker.
    Moon A; Park JY; Sung JY; Park YK; Kim YW
    Pathology; 2012 Oct; 44(6):534-9. PubMed ID: 22935977
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic significance of the expression of MUC1 and collagen type IV in advanced gastric carcinoma.
    Ando H; Aihara R; Ohno T; Ogata K; Mochiki E; Kuwano H
    Br J Surg; 2009 Aug; 96(8):901-9. PubMed ID: 19591170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of raf kinase inhibitor protein expression on metastasis and progression of human breast cancer.
    Li HZ; Gao Y; Zhao XL; Liu YX; Sun BC; Yang J; Yao Z
    Mol Cancer Res; 2009 Jun; 7(6):832-40. PubMed ID: 19531568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prognostic significance of the mucin phenotype of gastric adenocarcinoma and its relationship with histologic classifications.
    Lee OJ; Kim HJ; Kim JR; Watanabe H
    Oncol Rep; 2009 Feb; 21(2):387-93. PubMed ID: 19148512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High expression of PRL-3 can promote growth of gastric cancer and exhibits a poor prognostic impact on patients.
    Wang Z; Cai SR; He YL; Zhan WH; Chen CQ; Cui J; Wu WH; Wu H; Song W; Zhang CH; Peng JJ; Huang XH
    Ann Surg Oncol; 2009 Jan; 16(1):208-19. PubMed ID: 19009246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic significance of insulin-like growth factor II mRNA-binding protein 3 expression in gastric adenocarcinoma.
    Jeng YM; Wang TH; Lu SH; Yuan RH; Hsu HC
    Br J Surg; 2009 Jan; 96(1):66-73. PubMed ID: 19109797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of Cullin1 is associated with poor prognosis of patients with gastric cancer.
    Bai J; Zhou Y; Chen G; Zeng J; Ding J; Tan Y; Zhou J; Li G
    Hum Pathol; 2011 Mar; 42(3):375-83. PubMed ID: 21190721
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of MAP4K4 is associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma.
    Liang JJ; Wang H; Rashid A; Tan TH; Hwang RF; Hamilton SR; Abbruzzese JL; Evans DB; Wang H
    Clin Cancer Res; 2008 Nov; 14(21):7043-9. PubMed ID: 18981001
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Expression of transcription factor Sp1 in human gastric cancer tissue and its correlation with prognosis].
    Wang LW; Li Q; Hua ZL; Zhou F; Keping X; Daoyan W; Yao J; Ajani J
    Zhonghua Zhong Liu Za Zhi; 2007 Feb; 29(2):107-11. PubMed ID: 17645844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative analysis of breast cancer tissue microarrays shows high cox-2 expression is associated with poor outcome.
    Zerkowski MP; Camp RL; Burtness BA; Rimm DL; Chung GG
    Cancer Invest; 2007 Feb; 25(1):19-26. PubMed ID: 17364553
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Additive effect on survival of Raf kinase inhibitor protein and signal transducer and activator of transcription 3 in high-grade glioma.
    Maresch J; Birner P; Zakharinov M; Toumangelova-Uzeir K; Natchev S; Guentchev M
    Cancer; 2011 Jun; 117(11):2499-504. PubMed ID: 24048798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.